We found that TGF-β1 treatment significantly diminished mRNA and protein levels of SH2B3 in cancer cells while transfection of cells with OE-SH2B3 restored SH2B3 levels (Supplementary Fig. 2A, B). Here, SH2B3 is linked to cancer.